Monograph Details
|
|
Musculoskeletal Disorders
> Muscle spasms
|
|
MESTINON INJECTION |
| Manufacturer |
|
Valeant Pharmaceuticals, Inc |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Cholinesterase inhibitor. |
| Generic Name |
|
Pyridostigmine bromide 5mg/mL; amp. |
| Also |
• MESTINON
• MESTINON SYRUP
• MESTINON TIMESPAN
|
| Indications |
|
Myasthenia gravis. |
| Children |
|
Not recommended. |
| Adults |
|
One-thirtieth (1/30th) of oral dose IM or very slow IV inj. |
| Contraindications |
|
Intestinal or urinary obstruction. |
| Precautions |
|
Bronchial asthma. Cardiac dysrhythmias (inj). Monitor for cholinergic and myasthenic crisis, differentiate and treat (see literature). Pregnancy. Nursing mothers. |
| Interactions |
|
Reversal of nondepolarizing muscle relaxants. Antagonized by atropine. |
| Adverse Reactions |
|
GI upset, increased salivation and bronchial secretions, miosis and diaphoresis, muscle cramps, fasciculation and weakness, thrombophlebitis (inj). |
| How Supplied |
Tabs—100, 500
Syrup—pt
Timespan—100
Amp (2mL)—10 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
